• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[布宜诺斯艾利斯市艾滋病患者的治疗依从性及家庭与医院的距离]

[Retention in care and distance between home and hospital in HIV patients of Buenos Aires City].

作者信息

Blugerman Gabriela Alejandra, Valiente José Antonio, Cesar Carina, Yamamoto Cleyton, Sued Omar, Cahn Pedro

机构信息

División Infectología, Hospital General de Agudos Juan A. Fernández, Buenos Aires, Argentina.

Fundación Huésped, Buenos Aires, Argentina.

出版信息

Actual SIDA Infectol. 2018 Dec;26(98):54-60. doi: 10.52226/revista.v26i98.21.

DOI:10.52226/revista.v26i98.21
PMID:36727083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9886959/
Abstract

BACKGROUND

Distance from patient's home to the hospital has been proposed as one of the limiting factors for patient's retention in care.

METHODS

Retrospective cohort study of HIV+ patients 18 years or older who had their first clinical visit between 2011 and 2013 at a reference center in Buenos Aires, Argentina. Patients were considered to be retained in care if they had>=1 clinical visit, laboratory markers (VL and/or CD4 count) and/or ARVs pick-up during the year after their first clinical visit. Each patient address's latitude-longitude was obtained using Google Maps web service. Home-hospital distance and travel time were obtained with Google Maps Distance Matrix API service.

RESULTS

Of 1020 patients who started follow-up, 15 died and 158 were transferred to another site. Of the remaining, 816 (96.3%) had identifiable address in their electronic medical record. Median age at the time of the first visit was 33 (IQR 27-41) years, 654 (77.9%) patients were male. Median home-hospital distance was 10.3 (IQR 4.4-34.7) km and median travel time was 58.5 (IQR 35-102.5) minutes. 730 patients (89.5%; CI 87.1-91.5%) remained in follow-up after 1 year of their first visit. We didńt find association between travel time and home-hospital distance with retention in this population.

CONCLUSIONS

In our study, distance between home and the care center was not associated with lower retention one year after first visit in adult HIV patients attending a public hospital.

摘要

背景

患者住所与医院的距离被认为是影响患者持续接受治疗的限制因素之一。

方法

对2011年至2013年期间在阿根廷布宜诺斯艾利斯一家参考中心首次进行临床就诊的18岁及以上HIV阳性患者进行回顾性队列研究。如果患者在首次临床就诊后的一年内有≥1次临床就诊、实验室检查指标(病毒载量和/或CD4细胞计数)和/或抗逆转录病毒药物领取记录,则被视为持续接受治疗。使用谷歌地图网络服务获取每位患者住址的经纬度。通过谷歌地图距离矩阵应用程序编程接口服务获取住所到医院的距离和出行时间。

结果

在开始随访的1020名患者中,15人死亡,158人转至其他机构。其余患者中,816人(96.3%)在其电子病历中有可识别的地址。首次就诊时的中位年龄为33岁(四分位间距27 - 41岁),654名(77.9%)患者为男性。住所到医院的中位距离为10.3千米(四分位间距4.4 - 34.7千米),中位出行时间为58.5分钟(四分位间距35 - 102.5分钟)。首次就诊1年后,730名患者(89.5%;置信区间87.1 - 91.5%)仍在随访中。我们未发现该人群的出行时间和住所到医院的距离与持续接受治疗之间存在关联。

结论

在我们的研究中,对于在公立医院就诊的成年HIV患者,首次就诊一年后,住所与治疗中心之间的距离与较低的持续治疗率无关。

相似文献

1
[Retention in care and distance between home and hospital in HIV patients of Buenos Aires City].[布宜诺斯艾利斯市艾滋病患者的治疗依从性及家庭与医院的距离]
Actual SIDA Infectol. 2018 Dec;26(98):54-60. doi: 10.52226/revista.v26i98.21.
2
The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospital.阿根廷布宜诺斯艾利斯的艾滋病病毒治疗流程:一家三级转诊医院的结果
Rev Panam Salud Publica. 2016 Dec;40(6):448-454.
3
High retention in HIV care at a tertiary care centre in Toronto, Canada.加拿大多伦多一家三级护理中心的艾滋病护理高留存率。
AIDS Care. 2018 Feb;30(2):246-254. doi: 10.1080/09540121.2017.1349278. Epub 2017 Jul 5.
4
Commentary on: "Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial." Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJ, Krainer M, Houede N, Santos R, Mahammedi H, Ng S, Maio M, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld E, Sengeløv L, Hansen S, Logothetis C, Beer TM, McHenry MB, Gagnier P, Liu D, Gerritsen WR, CA184-043 Investigators. Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA, Electronic address: kwon.eugene@mayo.edu; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA; Institut Gustave Roussy, University of Paris-Sud, Villejuif, France; Institut Gustave Roussy, Villejuif, France; VU University Medical Centre, Amsterdam, Netherlands; Vienna General Hospital, Medical University Vienna, Vienna, Austria; Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France; Centro Médico Austral, Buenos Aires, Argentina; Centre Jean Perrin, Clermont-Ferrand, France; St John of God Hospital, Subiaco, WA, Australia; University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy; Hospital de Caridade de Ijuí, Ijuí, Brazil; Nottingham University Hospital, Nottingham, UK; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania; Hospital Británico de Buenos Aires, Buenos Aires, Argentina; Herlev Hospital, Herlev, Denmark; Odense University Hospital, Odense, Denmark; University of Texas MD Anderson Cancer Center, Houston,关于“多西他赛化疗后进展的转移性去势抵抗性前列腺癌患者放疗后伊匹木单抗与安慰剂对比研究(CA184 - 043):一项多中心、随机、双盲、3期试验”的述评。权恩东(Kwon ED)、德雷克·C·G(Drake CG)、舍尔·H·I(Scher HI)、菲扎齐·K(Fizazi K)、博西·A(Bossi A)、范登·埃尔特韦赫·A·J(van den Eertwegh AJ)、克莱纳·M(Krainer M)、胡德·N(Houede N)、桑托斯·R(Santos R)、马哈梅迪·H(Mahammedi H)、吴思(Ng S)、马约·M(Maio M)、弗兰克·F·A(Franke FA)、桑达尔·S(Sundar S)、阿加瓦尔·N(Agarwal N)、伯格曼·A·M(Bergman AM)、丘莱亚努·T·E(Ciuleanu TE)、科尔本费尔德·E(Korbenfeld E)、森格洛夫·L(Sengeløv L)、汉森·S(Hansen S)、洛戈塞蒂斯·C(Logothetis C)、比尔·T·M(Beer TM)、麦克亨利·M·B(McHenry MB)、加尼耶·P(Gagnier P)、刘丹(Liu D)、格里特森·W·R(Gerritsen WR),CA184 - 043研究团队。美国明尼苏达州罗切斯特市梅奥诊所泌尿外科、免疫学系及梅奥诊所综合癌症中心,电子邮箱:kwon.eugene@mayo.edu;美国马里兰州巴尔的摩市约翰·霍普金斯西德尼·金梅尔综合癌症中心及布雷迪泌尿外科研究所;美国纽约州纽约市纪念斯隆凯特琳癌症中心及威尔康乃尔医学院;法国巴黎 - 萨克雷大学古斯塔夫·鲁西研究所,维勒瑞夫;法国古斯塔夫·鲁西研究所,维勒瑞夫;荷兰阿姆斯特丹VU大学医学中心;奥地利维也纳医科大学维也纳总医院;法国波尔多贝戈涅研究所;法国尼姆卡勒莫医院;阿根廷布宜诺斯艾利斯澳大利亚医学中心;法国克莱蒙费朗让·佩兰中心;澳大利亚西澳大利亚州苏比亚科圣若翰医院;意大利锡耶纳大学医院、托斯卡纳肿瘤研究所;巴西伊茹伊慈善医院;英国诺丁汉大学医院;美国犹他州盐湖城犹他大学亨茨曼癌症研究所;荷兰阿姆斯特丹荷兰癌症研究所及安东尼·范·列文虎克医院;罗马尼亚克卢日 - 纳波卡肿瘤研究所及尤利乌·哈蒂根努医科药学院;阿根廷布宜诺斯艾利斯英国医院;丹麦赫勒夫医院;丹麦欧登塞大学医院;美国得克萨斯大学MD安德森癌症中心,休斯顿
Urol Oncol. 2016 May;34(5):249-50. doi: 10.1016/j.urolonc.2015.03.013. Epub 2015 Apr 20.
5
Validation of Retention in HIV Care Status Using the New York City HIV Surveillance Registry and Clinical Care Data From a Large HIV Care Center.利用纽约市艾滋病毒监测登记处和大型艾滋病毒护理中心的临床护理数据验证艾滋病毒护理状态的留存情况
J Public Health Manag Pract. 2017 Nov/Dec;23(6):564-570. doi: 10.1097/PHH.0000000000000515.
6
Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa.估算艾滋病毒护理中的保留率,考虑到患者转移:南非的一项全国实验室队列研究。
PLoS Med. 2018 Jun 11;15(6):e1002589. doi: 10.1371/journal.pmed.1002589. eCollection 2018 Jun.
7
Optimizing Travel Time to Outpatient Interventional Radiology Procedures in a Multi-Site Hospital System Using a Google Maps Application.利用谷歌地图应用程序优化多院区医院系统门诊介入放射学流程的出行时间。
J Digit Imaging. 2018 Oct;31(5):591-595. doi: 10.1007/s10278-018-0054-2.
8
Using national laboratory data to assess cumulative frequency of linkage after transfer to community-based HIV clinics in South Africa.利用国家实验室数据评估南非转至社区为基础的艾滋病毒诊所后的累计连接频率。
J Int AIDS Soc. 2019 Jun;22(6):e25326. doi: 10.1002/jia2.25326.
9
Physician Home Visit Patterns and Hospital Use Among Older Adults with Functional Impairments.医生家访模式与功能障碍老年人的住院使用情况。
J Am Geriatr Soc. 2020 Sep;68(9):2074-2081. doi: 10.1111/jgs.16639. Epub 2020 Jun 24.
10
Clinical and epidemiologic aspects of human immunodeficiency virus-1-infected children in Buenos Aires, Argentina.阿根廷布宜诺斯艾利斯市人类免疫缺陷病毒1型感染儿童的临床和流行病学特征
Int J Infect Dis. 2002 Mar;6(1):9-16. doi: 10.1016/s1201-9712(02)90129-3.

本文引用的文献

1
The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospital.阿根廷布宜诺斯艾利斯的艾滋病病毒治疗流程:一家三级转诊医院的结果
Rev Panam Salud Publica. 2016 Dec;40(6):448-454.
2
[Barriers to adherence and retention in public and private healthcare according to patients and health workers].[患者和医护人员视角下公共及私立医疗保健中依从性和持续性的障碍]
Actual SIDA Infectol. 2014 Nov;22(86):71-80.
3
Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia.成人HIV阳性患者坚持抗逆转录病毒药物治疗及持续接受治疗的障碍与促进因素:来自埃塞俄比亚的一项定性研究
PLoS One. 2014 May 14;9(5):e97353. doi: 10.1371/journal.pone.0097353. eCollection 2014.
4
Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.南非开始抗逆转录病毒治疗的成年人的预期寿命:队列研究的协作分析。
PLoS Med. 2013;10(4):e1001418. doi: 10.1371/journal.pmed.1001418. Epub 2013 Apr 9.
5
Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.35 岁及以上人类免疫缺陷病毒感染和人类免疫缺陷病毒阴性个体在长期队列研究中同时随访的病因特异性预期寿命,1984-2008 年。
Am J Epidemiol. 2013 Jan 15;177(2):116-25. doi: 10.1093/aje/kws321. Epub 2013 Jan 3.
6
Barriers to retention in care as perceived by persons living with HIV in rural Ethiopia: focus group results and recommended strategies.埃塞俄比亚农村地区艾滋病毒感染者所感知到的治疗留存障碍:焦点小组结果及推荐策略
J Int Assoc Provid AIDS Care. 2013 Jan-Feb;12(1):32-8. doi: 10.1177/1545109712456428. Epub 2012 Sep 19.
7
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.低收入国家接受联合抗逆转录病毒疗法者的预期寿命:乌干达的一项队列分析。
Ann Intern Med. 2011 Aug 16;155(4):209-16. doi: 10.7326/0003-4819-155-4-201108160-00358. Epub 2011 Jul 18.
8
Prevention of HIV-1 infection with early antiretroviral therapy.早期抗逆转录病毒疗法预防 HIV-1 感染。
N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.
9
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.参与 HIV 护理的范围及其与预防 HIV 感染的检测和治疗策略的相关性。
Clin Infect Dis. 2011 Mar 15;52(6):793-800. doi: 10.1093/cid/ciq243.
10
A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: implications for targeted interventions.一项关于美国东南部农村地区 HIV 阳性妇女保持治疗的障碍和促进因素的定性研究:对针对性干预的启示。
AIDS Patient Care STDS. 2010 Aug;24(8):515-20. doi: 10.1089/apc.2010.0065.